Advertisement

Efficiency, Safety, and Quality of Life After Transcatheter Aortic Valve Implantation Performed With Moderate Sedation Versus General Anesthesia

Published:January 08, 2020DOI:https://doi.org/10.1016/j.amjcard.2020.01.002
      There is growing interest in “minimalist” transcatheter aortic valve implantation (M-TAVI), performed with conscious sedation instead of general anesthesia (GA-TAVI). We assessed the impact of M-TAVI on procedural efficiency, long-term safety, and quality of life (QoL) in 477 patients with severe aortic stenosis (82 years, women 50%, STS 5.0), who underwent M-TAVI (n = 278) or GA-TAVI (n = 199). M-TAVI patients were less likely to have NYHA Class ≥3, valve-in-valve TAVI, and receive self-expanding valves. M-TAVI was completed without conversion to GA in 269 (97%) patients. M-TAVI was more efficient that GA-TAVI including shorter lengths of stay (2 vs 3 days, p <0.0001), higher likelihood of being discharged home (87% vs 72%, p <0.0001), less use of blood transfusions (10% vs 22%, p = 0.0008), inotropes (13% vs 32%, p <0.0001), contrast volume (50 vs 90 ml, p <0.0001), fluoroscopy time (20 vs 24 minute, p <0.0001), and need for >1 valves (0.4 vs 5.5%, p = 0.0004). At 1-month, death/stroke (M-TAVI vs GA-TAVI 4.0 vs 6.5%) and a “safety composite” end point (death, stroke, transient ischemic attack, myocardial infarction, new dialysis, major vascular complication, major or life-threatening bleeding, and new pacemaker: 17.6% vs 21.1%) were similar (p = NS for both). At a median follow-up of 365 days, survival curves showed similar incidence of death/stroke as well as the safety composite end point between the groups. QoL scores were similar at baseline and 1-month after TAVI. In multivariable analyses, M-TAVI showed significant improvements in all parameters of procedural efficiency. In conclusion, M-TAVI is more efficient than GA-TAVI, with similar safety at 1-month and long-term, and similar QoL scores at 1 month.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kapadia SR
        • Leon MB
        • Makkar RR
        • Tuzcu EM
        • Svensson LG
        • Kodali S
        • Webb JG
        • Mack MJ
        • Douglas PS
        • Thourani VH
        • Babaliaros VC
        • Herrmann HC
        • Szeto WY
        • Pichard AD
        • Williams MR
        • Fontana GP
        • Miller DC
        • Anderson WN
        • Akin JJ
        • Davidson MJ
        • Smith CR
        • PARTNER trial investigators
        5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
        Lancet. 2015; 385: 2485-2491
        • Mack MJ
        • Leon MB
        • Smith CR
        • Miller DC
        • Moses JW
        • Tuzcu EM
        • Webb JG
        • Douglas PS
        • Anderson WN
        • Blackstone EH
        • Kodali SK
        • Makkar RR
        • Fontana GP
        • Kapadia S
        • Bavaria J
        • Hahn RT
        • Thourani VH
        • Babaliaros V
        • Pichard A
        • Herrmann HC
        • Brown DL
        • Williams M
        • Akin J
        • Davidson MJ
        • Svensson LG
        • PARTNER trial investigators
        5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
        Lancet. 2015; 385: 2477-2484
        • Thourani VH
        • Forcillo J
        • Szeto WY
        • Kodali SK
        • Blackstone EH
        • Lowry AM
        • Semple M
        • Rajeswaran J
        • Makkar RR
        • Williams MR
        • Bavaria JE
        • Herrmann HC
        • Maniar HS
        • Babaliaros VC
        • Smith CR
        • Trento A
        • Corso PJ
        • Pichard AD
        • Miller DC
        • Svensson LG
        • Kapadia S
        • Ailawadi G
        • Suri RM
        • Greason KL
        • Hahn RT
        • Jaber WA
        • Alu MC
        • Leon MB
        • Mack MJ
        • PARTNER Trial Investigators
        Outcomes in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A.
        Ann Thorac Surg. 2018; 105: 1322-1329
        • Popma JJ
        • Adams DH
        • Reardon MJ
        • Yakubov SJ
        • Kleiman NS
        • Heimansohn D
        • Hermiller Jr, J
        • Hughes GC
        • Harrison JK
        • Coselli J
        • Diez J
        • Kafi A
        • Schreiber T
        • Gleason TG
        • Conte J
        • Buchbinder M
        • Deeb GM
        • Carabello B
        • Serruys PW
        • Chenoweth S
        • Oh JK
        • CoreValve United States Clinical, Investigators
        Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
        J Am Coll Cardiol. 2014; 63: 1972-1981
        • Popma JJ
        • Deeb GM
        • Yakubov SJ
        • Mumtaz M
        • Gada H
        • O'Hair D
        • Bajwa T
        • Heiser JC
        • Merhi W
        • Kleiman NS
        • Askew J
        • Sorajja P
        • Rovin J
        • Chetcuti SJ
        • Adams DH
        • Teirstein PS
        • Zorn 3rd, GL
        • Forrest JK
        • Tchetche D
        • Resar J
        • Walton A
        • Piazza N
        • Ramlawi B
        • Robinson N
        • Petrossian G
        • Gleason TG
        • Oh JK
        • Boulware MJ
        • Qiao H
        • Mugglin AS
        • Reardon MJ
        • Evolut Low Risk Trial, Investigators
        Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
        N Engl J Med. 2019; 380: 1706-1715
        • Popma JJ
        • Reardon MJ
        • Khabbaz K
        • Harrison JK
        • Hughes GC
        • Kodali S
        • George I
        • Deeb GM
        • Chetcuti S
        • Kipperman R
        • Brown J
        • Qiao H
        • Slater J
        • Williams MR
        Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the Evolut R U.S. Study.
        JACC Cardiovasc Interv. 2017; 10: 268-275
        • Reardon MJ
        • Adams DH
        • Kleiman NS
        • Yakubov SJ
        • Coselli JS
        • Deeb GM
        • Gleason TG
        • Lee JS
        • Hermiller Jr, JB
        • Chetcuti S
        • Heiser J
        • Merhi W
        • Zorn 3, GL
        • Tadros P
        • Robinson N
        • Petrossian G
        • Hughes GC
        • Harrison JK
        • Maini B
        • Mumtaz M
        • Conte JV
        • Resar JR
        • Aharonian V
        • Pfeffer T
        • Oh JK
        • Qiao H
        • Popma JJ
        2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement.
        J Am Coll Cardiol. 2015; 66: 113-121
        • Attizzani GF
        • Patel SM
        • Dangas GD
        • Szeto WY
        • Sorajja P
        • Reardon MJ
        • Popma JJ
        • Kodali S
        • Chenoweth S
        • Costa MA
        Comparison of local versus general anesthesia following transfemoral transcatheter self-expanding aortic valve implantation (from the Transcatheter Valve Therapeutics Registry).
        Am J Cardiol. 2019; 123: 419-425
        • D'Errigo P
        • Ranucci M
        • Covello RD
        • Biancari F
        • Rosato S
        • Barbanti M
        • Onorati F
        • Tamburino C
        • Santoro G
        • Grossi C
        • Santini F
        • Bontempi K
        • Fusco D
        • Seccareccia F
        • Observant Research Group
        Outcome after general anesthesia versus monitored anesthesia care in transfemoral transcatheter aortic valve replacement.
        J Cardiothorac Vasc Anesth. 2016; 30: 1238-1243
        • Husser O
        • Fujita B
        • Hengstenberg C
        • Frerker C
        • Beckmann A
        • Mollmann H
        • Walther T
        • Bekeredjian R
        • Bohm M
        • Pellegrini C
        • Bleiziffer S
        • Lange R
        • Mohr F
        • Hamm CW
        • Bauer T
        • Ensminger S
        • Gary Executive Board
        Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry.
        JACC Cardiovasc Interv. 2018; 11: 567-578
        • Hyman MC
        • Vemulapalli S
        • Szeto WY
        • Stebbins A
        • Patel PA
        • Matsouaka RA
        • Anwaruddin S
        • Kobayashi T
        • Desai ND
        • Vallabhajosyula P
        • McCarthy FH
        • Li R
        • Bavaria JE
        • Giri J
        Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: insights from the national cardiovascular data registry society of thoracic surgeons/american college of cardiology transcatheter valve therapy registry.
        Circulation. 2017; 136: 2132-2140
        • Jensen HA
        • Condado JF
        • Devireddy C
        • Binongo J
        • Leshnower BG
        • Babaliaros V
        • Sarin EL
        • Lerakis S
        • Guyton RA
        • Stewart JP
        • Syed AQ
        • Mavromatis K
        • Kaebnick B
        • Rajaei MH
        • Tsai LL
        • Rahman A
        • Simone A
        • Keegan P
        • Block PC
        • Thourani VH
        Minimalist transcatheter aortic valve replacement: the new standard for surgeons and cardiologists using transfemoral access?.
        J Thorac Cardiovasc Surg. 2015; 150: 833-839
        • Mayr NP
        • Michel J
        • Bleiziffer S
        • Tassani P
        • Martin K
        Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI).
        J Thorac Dis. 2015; 7: 1518-1526
        • Wood DA
        • Lauck SB
        • Cairns JA
        • Humphries KH
        • Cook R
        • Welsh R
        • Leipsic J
        • Genereux P
        • Moss R
        • Jue J
        • Blanke P
        • Cheung A
        • Ye J
        • Dvir D
        • Umedaly H
        • Klein R
        • Rondi K
        • Poulter R
        • Stub D
        • Barbanti M
        • Fahmy P
        • Htun N
        • Murdoch D
        • Prakash R
        • Barker M
        • Nickel K
        • Thakkar J
        • Sathananthan J
        • Tyrell B
        • Al-Qoofi F
        • Velianou JL
        • Natarajan MK
        • Wijeysundera HC
        • Radhakrishnan S
        • Horlick E
        • Osten M
        • Buller C
        • Peterson M
        • Asgar A
        • Palisaitis D
        • Masson JB
        • Kodali S
        • Nazif T
        • Thourani V
        • Babaliaros VC
        • Cohen DJ
        • Park JE
        • Leon MB
        • Webb JG
        The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVI Study.
        JACC Cardiovasc Interv. 2019; 12: 459-469
        • Holper EM
        • Kim RJ
        • Mack M
        • Brown D
        • Brinkman W
        • Herbert M
        • Stewart W
        • Vance K
        • Bowers B
        • Dewey T
        Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVI.
        Cath Cardiovasc Interv. 2014; 83: 457-464
        • Hayek SS
        • Corrigan 3rd, FE
        • Condado JF
        • Lin S
        • Howell S
        • MacNamara JP
        • Zheng S
        • Keegan P
        • Thourani V
        • Babaliaros VC
        • Lerakis S
        Paravalvular regurgitation after transcatheter aortic valve replacement: comparing transthoracic versus transesophageal echocardiographic guidance.
        J Am Soc Echo. 2017; 30: 533-540
        • Arnold SV
        • Spertus JA
        • Vemulapalli S
        • Li Z
        • Matsouaka RA
        • Baron SJ
        • Vora AN
        • Mack MJ
        • Reynolds MR
        • Rumsfeld JS
        • Cohen DJ
        Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry.
        JAMA Cardiol. 2017; 2: 409-416
        • Droppa M
        • Borst O
        • Katzenberger T
        • Krause R
        • Grasshoff C
        • Gawaz M
        • Geisler T
        Comparison of safety and periprocedural complications of transfemoral aortic valve replacement under local anaesthesia: minimalist versus complete Heart Team.
        Euro Intervent. 2019; 14: e1819-e1825
        • Hosoba S
        • Yamamoto M
        • Shioda K
        • Sago M
        • Koyama Y
        • Shimura T
        • Kagase A
        • Tada N
        • Naganuma T
        • Araki M
        • Yamanaka F
        • Shirai S
        • Watanabe Y
        • Hayashida K
        Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry.
        Interact Cardiovasc Thorac Surg. 2018; 26: 420-424
        • Condado JF
        • Haider MN
        • Lerakis S
        • Keegan P
        • Caughron H
        • Thourani VH
        • Devireddy C
        • Leshnower B
        • Mavromatis K
        • Sarin EL
        • Stewart J
        • Guyton R
        • Forcillo J
        • Patel A
        • Simone A
        • Block PC
        • Babaliaros V
        Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?.
        Cath Cardiovasc Interv. 2017; 89: 775-780
        • Kotronias RA
        • Teitelbaum M
        • Webb JG
        • Mylotte D
        • Barbanti M
        • Wood DA
        • Ballantyne B
        • Osborne A
        • Solo K
        • Kwok CS
        • Mamas MA
        • Bagur R
        Early versus standard discharge after transcatheter aortic valve replacement: a systematic review and meta-analysis.
        JACC Cardiovasc Interv. 2018; 11: 1759-1771